All News
Holiday Alone Time; Depression Indication for Antipsychotic? Lithium and CKD
(MedPage Today) -- More than half of respondents in a national survey from Ohio State University said it's very important to their mental health to have adequate time alone during the holidays.
Read MoreSupreme Court Appears Likely to Uphold Bans on Transgender Care for Minors
(MedPage Today) -- Hearing a high-profile culture-war clash, a majority of the Supreme Court seemed reluctant Wednesday to block Tennessee's ban on gender-affirming care for minors.
Read MoreE.P.A. Again Seeks Limits on a Harmful Pesticide
After a court overturned a ban, the agency has proposed restricting chlorpyrifos to 11 food crops, illustrating the limits of federal regulation.
Read MoreRFK Jr.'s Extremist Views on CDC; Hysterectomy Misconceptions; Blowing Up the NIH?
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. RFK Jr.
Read MoreNearly 30% of U.S. Drugstores Closed in One Decade, Study Shows
(MedPage Today) -- Nearly three out of 10 U.S. drugstores that were open during the previous decade had closed by 2021, new research shows.
Read MoreMore DEI Bans Will Have Dire Side Effects for Public Health
(MedPage Today) -- As a registered nurse, I've seen how cross-cultural misunderstandings can lead to poor care for my fellow Hispanic patients and families.
Read MoreTrans care at the Supreme Court and an RFK Jr. tax doc drop
Good morning! Another health care case comes to the Supreme Court today. See my preview below, and keep an eye out for more coverage later today.
Read MoreSTAT+: Talks over big end-of-year health package heat up in Congress
Negotiations over a large health care policy package are heating up as Congress hurtles toward a government funding deadline
Read MoreLive Updates: Supreme Court Hearing Major Trans Rights Case
Families and a doctor are challenging a Tennessee ban on some forms of medical care for transgender youth. Laws in more than 20 states could be affected.
Read MoreITP Drug Disappoints in Hospitalized COVID Patients With Hypoxemia
(MedPage Today) -- The spleen tyrosine kinase inhibitor fostamatinib (Tavalisse) did not improve outcomes in adults hospitalized with COVID-19 and hypoxemia, a phase III randomized trial showed.
Read More